An open label, randomized study to investigate the safety of weekly pentosan polysulfate injections in adult patients with Mucopolysaccharidosis Type I receiving enzyme replacement therapy.
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2015
Price : $35 *
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Mucopolysaccharidosis I
- Focus Adverse reactions
- Sponsors Multiplex Pharma Holdings
- 31 Aug 2018 Biomarkers information updated
- 04 Apr 2015 Status changed from recruiting to suspended, according to European Clinical Trials Database record.
- 18 Jun 2014 New trial record